Banque de Luxembourg’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.88M Buy
100,738
+4,057
+4% +$327K 3.72% 9
2026
Q1
$8.38M Sell
96,681
-10,554
-10% -$1.01M 4.33% 9
2025
Q4
$10.3M Buy
107,235
+63
+0.1% +$6.12K 4.39% 8
2025
Q3
$10.2M Sell
107,172
-1,272
-1% -$117K 5.28% 6
2025
Q2
$9.74M Sell
108,444
-260
-0.2% -$22K 5.58% 6
2025
Q1
$9.77M Buy
108,704
+3,951
+4% +$354K 5.59% 6
2024
Q4
$8.4M Buy
+104,753
New +$9.07M 4.52% 8

Other funds holding MDT

Banque de Luxembourg's MDT Position: Q2 2026 in Review

Banque de Luxembourg increased its Medtronic (MDT) stake by 4.2% in Q2 2026, buying an estimated $327K and bringing the position to 100,738 shares worth $7.88M. The position accounts for 3.72% of the portfolio, ranked #9.

Banque de Luxembourg first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.3M in Q4 2025. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Banque de Luxembourg held 100,738 shares of Medtronic worth $7.88M as of Q2 2026.
  • Banque de Luxembourg bought 4,057 Medtronic shares in Q2 2026, an estimated $327K.
  • Medtronic made up 3.72% of Banque de Luxembourg's portfolio in Q2 2026, its #9 holding.
  • Banque de Luxembourg first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Banque de Luxembourg's Medtronic position peaked at $10.3M in Q4 2025.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Banque de Luxembourg's 13F filing for Q2 2026, filed 9 Jul 2026.